These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14095161)

  • 1. [RESEARCH ON THE ENZYMATIC ACTIVITIES OF PLASMIN AND STREPTOKINASE].
    VAUXSAINT CYR
    Biol Med (Paris); 1963; 52():611-30. PubMed ID: 14095161
    [No Abstract]   [Full Text] [Related]  

  • 2. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 3. INACTIVATION OF STREPTOKINASE BY BOVINE PLASMIN.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():529-32. PubMed ID: 14086328
    [No Abstract]   [Full Text] [Related]  

  • 4. THE INTERACTION OF STREPTOKINASE WITH PLASMINOGEN. I. FUNCTIONAL PROPERTIES OF THE ACTIVATED ENZYME.
    MARKUS G; WERKHEISER WC
    J Biol Chem; 1964 Aug; 239():2637-43. PubMed ID: 14235547
    [No Abstract]   [Full Text] [Related]  

  • 5. [FIBRINOLYSIS INHIBITORS AND DETERMINATION OF PHYSIOLOGICAL AND PATHOLOGICAL ANTIPLASMIN ACTIVITY].
    MORIAU M; DE VRIES SI; DIK HJ
    Thromb Diath Haemorrh; 1964 Jan; 10():355-78. PubMed ID: 14113376
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasminogen and plasmin. I. Studies on activation of plasminogen and on inactivation of plasmin].
    KOWALSKI E; LATALLO Z; NIEWIAROWSKI S
    Acta Biochim Pol; 1956; 3(1):87-108. PubMed ID: 13338989
    [No Abstract]   [Full Text] [Related]  

  • 7. An activator system in blood indispensable for formation of plasmin by streptokinase.
    MULLERTZ S; LASSEN M
    Proc Soc Exp Biol Med; 1953 Feb; 82(2):264-8. PubMed ID: 13037866
    [No Abstract]   [Full Text] [Related]  

  • 8. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 9. The esterase activities of human plasmin during purification and subsequent activation by streptokinase or glycerol.
    ROBERTS PS
    J Biol Chem; 1960 Aug; 235():2262-6. PubMed ID: 14437833
    [No Abstract]   [Full Text] [Related]  

  • 10. Formation and properties of the activator of plasminogen and of human and bovine plasmin.
    MULLERTZ S
    Biochem J; 1955 Nov; 61(3):424-34. PubMed ID: 13269378
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysin and related plasma esterases in patients with cirrhosis.
    PERNOKAS LN; BROWN M
    Gastroenterology; 1963 Jan; 44():44-7. PubMed ID: 13942515
    [No Abstract]   [Full Text] [Related]  

  • 12. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 13. ON THE INHIBITION OF PLASMIN BY STREPTOKINASE.
    RIMON S; RIMON A
    Life Sci (1962); 1964 Mar; 3():231-4. PubMed ID: 14151224
    [No Abstract]   [Full Text] [Related]  

  • 14. INCREASE IN FIBRINOLYTIC ACTIVITY BY VENOUS OCCLUSION.
    HOLEMANS R
    J Appl Physiol; 1963 Nov; 18():1123-9. PubMed ID: 14080731
    [No Abstract]   [Full Text] [Related]  

  • 15. THE STREPTOKINASE ACTIVATION OF HUMAN PLASMINOGEN. DIRECT ANALYSIS OF THE ACTIVATION MIXTURE.
    RIFE U; SHULMAN S
    Thromb Diath Haemorrh; 1963 Nov; 10():133-45. PubMed ID: 14081275
    [No Abstract]   [Full Text] [Related]  

  • 16. THE CASEINOLYTIC METHOD FOR DETERMINATION OF PLASMINOGEN-PLASMIN IN HUMAN PLASMA AND SERUM.
    JACOBSEN CD
    Scand J Clin Lab Invest; 1964; 16():372-82. PubMed ID: 14202017
    [No Abstract]   [Full Text] [Related]  

  • 17. FIBRINOGEN AS A PART OF PLATELET STRUCTURE.
    GOKCEN M; YUNIS E
    Nature; 1963 Nov; 200():590-1. PubMed ID: 14082244
    [No Abstract]   [Full Text] [Related]  

  • 18. USE OF CHROMIUM51-TAGGED CASEIN FOR THE DETERMINATION OF PROTEOLYTIC ACTIVITY.
    RITZ ND; RUBIN H
    J Lab Clin Med; 1964 Feb; 63():344-54. PubMed ID: 14125123
    [No Abstract]   [Full Text] [Related]  

  • 19. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR.
    GUTMAN M; RIMON A
    Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON A METHOD FOR THE DETERMINATION OF PLASMA FIBRINOLYTIC ACTIVITY].
    SHIRAI T
    Klin Wochenschr; 1964 Jun; 42():586-8. PubMed ID: 14236987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.